Publication date
January 2008
DOI Publisher
中国中西医结合杂志 Journal
1003-5370Abstract
老年急性白血病的年龄界限并不统一,从≥50岁到≥70岁都有学者采用,但在多数临床研究中采用≥60岁作为老年白血病的年龄界限.中文核心期刊要目总览(PKU)中国科技核心期刊(ISTIC)中国科学引文数据库(CSCD)010873-8742
老年急性白血病的年龄界限并不统一,从≥50岁到≥70岁都有学者采用,但在多数临床研究中采用≥60岁作为老年白血病的年龄界限.中文核心期刊要目总览(PKU)中国科技核心期刊(ISTIC)中国科学引文数据库(CSCD)010873-8742
Among patients with acute myeloid leukemia (AML), treatment regimens and outcomes may differ among y...
Background and Objectives. The prognosis of elderly patients with acute myelogenous leukemia (AML) i...
Acute myeloid leukemia (AML) is a disease predominantly of older adults. Treatment of AML in the eld...
目的:探讨老年急性白血病(AL)的临床特点,以利于有效治疗.方法:回顾分析50例60岁以上的老年AL患者的临床资料,包括年龄分布、基础疾病、主要症状、临床特征、骨髓(BM)象、染色体、免疫分型、化疗的...
OBJECTIVE: In older adults with acute myeloid leukemia (AML), the overall outcome is still dismal an...
With an increase in the incidence of acute myeloid leukemia with age, there is a worsening in organ ...
International audienceINTRODUCTION: Life expectancy in elderly patients with acute myeloid leukemia ...
Background: Even though acute myeloid leukemia (AML) occurs most commonly in adults ≥60 years, the t...
Objectives: Approximately 40-60% of acute myelogenous leukemia(AML) and 30% of acute lymphoblastic l...
Objective: To evaluate the therapeutic outcomes of acute myeloid leukemia (AML) in elderly patients....
<p><strong>Aim</strong><strong> </strong><strong>of</strong><strong> </strong><strong>research</stro...
International audienceThe treatment of very elderly patients (\textgreater/=70 years) with acute mye...
Objectives: Treatment of older patients with acute myeloid leukemia (AML) is still controversial. To...
Acute myeloid leukemia (AML), with an incidence increasing with age, is the most common acute leukem...
Among patients with acute myeloid leukemia (AML), treatment regimens and outcomes may differ among y...
Background and Objectives. The prognosis of elderly patients with acute myelogenous leukemia (AML) i...
Acute myeloid leukemia (AML) is a disease predominantly of older adults. Treatment of AML in the eld...
目的:探讨老年急性白血病(AL)的临床特点,以利于有效治疗.方法:回顾分析50例60岁以上的老年AL患者的临床资料,包括年龄分布、基础疾病、主要症状、临床特征、骨髓(BM)象、染色体、免疫分型、化疗的...
OBJECTIVE: In older adults with acute myeloid leukemia (AML), the overall outcome is still dismal an...
With an increase in the incidence of acute myeloid leukemia with age, there is a worsening in organ ...
International audienceINTRODUCTION: Life expectancy in elderly patients with acute myeloid leukemia ...
Background: Even though acute myeloid leukemia (AML) occurs most commonly in adults ≥60 years, the t...
Objectives: Approximately 40-60% of acute myelogenous leukemia(AML) and 30% of acute lymphoblastic l...
Objective: To evaluate the therapeutic outcomes of acute myeloid leukemia (AML) in elderly patients....
<p><strong>Aim</strong><strong> </strong><strong>of</strong><strong> </strong><strong>research</stro...
International audienceThe treatment of very elderly patients (\textgreater/=70 years) with acute mye...
Objectives: Treatment of older patients with acute myeloid leukemia (AML) is still controversial. To...
Acute myeloid leukemia (AML), with an incidence increasing with age, is the most common acute leukem...
Among patients with acute myeloid leukemia (AML), treatment regimens and outcomes may differ among y...
Background and Objectives. The prognosis of elderly patients with acute myelogenous leukemia (AML) i...
Acute myeloid leukemia (AML) is a disease predominantly of older adults. Treatment of AML in the eld...
Add to ORKG